Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells

Non-small cell lung cancer (NSCLC), comprising 85% of lung cancer cases, has been associated with resistance to chemo/radiotherapy. The hypoxic tumor micro-environment, where insufficient vasculature results in poor drug penetrance and sub-optimal chemotherapy in the tumor interiors contributes heav...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Shrikant, Mahajan, Divyank, Kaur, Prabhjot, Pandey, Namita, Sharma, Chandresh, Srivastava, Tapasya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342127/
https://www.ncbi.nlm.nih.gov/pubmed/27708247
http://dx.doi.org/10.18632/oncotarget.12378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342127/
https://www.ncbi.nlm.nih.gov/pubmed/27708247
http://dx.doi.org/10.18632/oncotarget.12378

Ejemplares similares